Brookline Capital Management Predicts FBRX Q2 Earnings

Forte Biosciences, Inc. (NASDAQ:FBRX – Free Report) – Equities research analysts at Brookline Capital Management issued their Q2 2025 earnings estimates for Forte Biosciences in a report released on Thursday, April 3rd. Brookline Capital Management analyst K. Raja expects that the company will post earnings per share of ($0.97) for the quarter. The consensus estimate […]